219 related articles for article (PubMed ID: 15808375)
1. Metamizol (dipyrone, optalgin) in pregnancy, is it safe? A prospective comparative study.
Bar-Oz B; Clementi M; Di Giantonio E; Greenberg R; Beer M; Merlob P; Arnon J; Ornoy A; Zimmerman DM; Berkovitch M
Eur J Obstet Gynecol Reprod Biol; 2005 Apr; 119(2):176-9. PubMed ID: 15808375
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy outcome after in utero exposure to itraconazole: a prospective cohort study.
Bar-Oz B; Moretti ME; Bishai R; Mareels G; Van Tittelboom T; Verspeelt J; Koren G
Am J Obstet Gynecol; 2000 Sep; 183(3):617-20. PubMed ID: 10992182
[TBL] [Abstract][Full Text] [Related]
3. Metoclopramide for nausea and vomiting of pregnancy: a prospective multicenter international study.
Berkovitch M; Mazzota P; Greenberg R; Elbirt D; Addis A; Schuler-Faccini L; Merlob P; Arnon J; Stahl B; Magee L; Moretti M; Ornoy A
Am J Perinatol; 2002 Aug; 19(6):311-6. PubMed ID: 12357422
[TBL] [Abstract][Full Text] [Related]
4. Fetal outcome after in utero exposure to cancer chemotherapy.
Zemlickis D; Lishner M; Degendorfer P; Panzarella T; Sutcliffe SB; Koren G
Arch Intern Med; 1992 Mar; 152(3):573-6. PubMed ID: 1546920
[TBL] [Abstract][Full Text] [Related]
5. First-trimester exposure to amoxycillin/clavulanic acid: a prospective, controlled study.
Berkovitch M; Diav-Citrin O; Greenberg R; Cohen M; Bulkowstein M; Shechtman S; Bortnik O; Arnon J; Ornoy A
Br J Clin Pharmacol; 2004 Sep; 58(3):298-302. PubMed ID: 15327589
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study.
Chun-Fai-Chan B; Koren G; Fayez I; Kalra S; Voyer-Lavigne S; Boshier A; Shakir S; Einarson A
Am J Obstet Gynecol; 2005 Mar; 192(3):932-6. PubMed ID: 15746694
[TBL] [Abstract][Full Text] [Related]
7. Pregnancy outcome after exposure to the probiotic Lactobacillus in early pregnancy.
Lee JE; Han JY; Choi JS; Ahn HK; Lee SW; Kim MH; Ryu HM; Yang JH; Nava-Ocampo AA; Koren G
J Obstet Gynaecol; 2012 Apr; 32(3):227-9. PubMed ID: 22369393
[TBL] [Abstract][Full Text] [Related]
8. Low dose methotrexate in the first trimester of pregnancy: results of a French collaborative study.
Lewden B; Vial T; Elefant E; Nelva A; Carlier P; Descotes J;
J Rheumatol; 2004 Dec; 31(12):2360-5. PubMed ID: 15570635
[TBL] [Abstract][Full Text] [Related]
9. Pregnancy outcome after gestational exposure to metronidazole: a prospective controlled cohort study.
Diav-Citrin O; Shechtman S; Gotteiner T; Arnon J; Ornoy A
Teratology; 2001 May; 63(5):186-92. PubMed ID: 11320529
[TBL] [Abstract][Full Text] [Related]
10. Pregnancy outcome following in utero exposure to bisphosphonates.
Levy S; Fayez I; Taguchi N; Han JY; Aiello J; Matsui D; Moretti M; Koren G; Ito S
Bone; 2009 Mar; 44(3):428-30. PubMed ID: 19059370
[TBL] [Abstract][Full Text] [Related]
11. Continuation of pregnancy after first-trimester exposure to mifepristone: an observational prospective study.
Bernard N; Elefant E; Carlier P; Tebacher M; Barjhoux CE; Bos-Thompson MA; Amar E; Descotes J; Vial T
BJOG; 2013 Apr; 120(5):568-74. PubMed ID: 23346916
[TBL] [Abstract][Full Text] [Related]
12. Pregnancy outcome of women inadvertently exposed to ribostamycin during early pregnancy: a prospective cohort study.
Lee SW; Han JY; Choi JS; Chung JH; Kim MY; Yang JH; Koong MK; Nava-Ocampo AA; Koren G
Reprod Toxicol; 2009 Apr; 27(2):196-8. PubMed ID: 19162171
[TBL] [Abstract][Full Text] [Related]
13. Pregnancy outcome after gestational exposure to the new macrolides: a prospective multi-center observational study.
Bar-Oz B; Diav-Citrin O; Shechtman S; Tellem R; Arnon J; Francetic I; Berkovitch M; Ornoy A
Eur J Obstet Gynecol Reprod Biol; 2008 Nov; 141(1):31-4. PubMed ID: 18760873
[TBL] [Abstract][Full Text] [Related]
14. Dipyrone use during pregnancy and adverse perinatal events.
da Silva Dal Pizzol T; Schüler-Faccini L; Mengue SS; Fischer MI
Arch Gynecol Obstet; 2009 Mar; 279(3):293-7. PubMed ID: 18568358
[TBL] [Abstract][Full Text] [Related]
15. Pregnancy outcome after first trimester exposure to corticosteroids: a prospective controlled study.
Gur C; Diav-Citrin O; Shechtman S; Arnon J; Ornoy A
Reprod Toxicol; 2004; 18(1):93-101. PubMed ID: 15013068
[TBL] [Abstract][Full Text] [Related]
16. Pregnancy outcomes after first trimester exposure to phentermine/fenfluramine.
Jones KL; Johnson KA; Dick LM; Felix RJ; Kao KK; Chambers CD
Teratology; 2002 Mar; 65(3):125-30. PubMed ID: 11877776
[TBL] [Abstract][Full Text] [Related]
17. Smoking habits, nicotine use, and congenital malformations.
Morales-Suárez-Varela MM; Bille C; Christensen K; Olsen J
Obstet Gynecol; 2006 Jan; 107(1):51-7. PubMed ID: 16394039
[TBL] [Abstract][Full Text] [Related]
18. Pregnancy outcome following fetal exposure to tiaprofenic acid in the first trimester.
Pastuszak A; Pinelli M; Koren G
Am J Perinatol; 1993 Sep; 10(5):354-7. PubMed ID: 8240592
[TBL] [Abstract][Full Text] [Related]
19. First trimester exposure to cefuroxime: a prospective cohort study.
Berkovitch M; Segal-Socher I; Greenberg R; Bulkowshtein M; Arnon J; Merlob P; Or-Noy A
Br J Clin Pharmacol; 2000 Aug; 50(2):161-5. PubMed ID: 10930968
[TBL] [Abstract][Full Text] [Related]
20. The safety of cetirizine during pregnancy. A prospective observational cohort study.
Weber-Schoendorfer C; Schaefer C
Reprod Toxicol; 2008 Sep; 26(1):19-23. PubMed ID: 18571373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
